Predicted protein targets (top 2)
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1445753 | 0.89 | CES2 (0.30) | CES2CES1 | |
| SCHEMBL38662699 | 0.78 | HDAC4 (0.30) | — | |
| SCHEMBL1162776 | 0.77 | CES2 (0.38) | CES2CES1 | |
| SCHEMBL31444457 | 0.77 | CES2 (0.38) | CES2CES1 | |
| Bromide SCHEMBL1445880 | 0.74 | CES2 (0.36) | CES2CES1 | |
| SCHEMBL1445878 | 0.74 | — | — | |
| SCHEMBL45430 | 0.72 | CES2 (0.53) | CES2CES1 | |
| SCHEMBL3975406 | 0.69 | CES2 (0.50) | CES2CES1 | |
| SCHEMBL11355080 | 0.69 | CES2 (0.50) | CES2CES1 | |
| Ammonia Solution, Strong SCHEMBL3047305 | 0.69 | CES2 (0.50) | CES2CES1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-109761820-B | Chemical synthesis method of 3',4',5 '-trifluoro- [1,1' -biphenyl ] -2-amine | 浙江工业大学 | 2022-03-25 | — | — | CN | claimed |
| US-8609574-B2 | In situ olefin polymerization catalyst system | PROMERUS LLC (US) | 2013-12-17 | — | — | US | claimed |
| EP-2296811-A2 | IN SITU OLEFIN POLYMERIZATION CATALYST SYSTEM | Promerus, LLC (US) | 2011-03-23 | — | — | EP | claimed |
| WO-2009132240-A2 | IN SITU OLEFIN POLYMERIZATION CATALYST SYSTEM | PROMERUS LLC (US) | 2009-10-29 | — | — | WO | claimed |
| US-20090270247-A1 | IN SITU OLEFIN POLYMERIZATION CATALYST SYSTEM | PROMERUS LLC (US) | 2009-10-29 | — | — | US | claimed |
| CN-109761820-B | Chemical synthesis method of 3',4',5 '-trifluoro- [1,1' -biphenyl ] -2-amine | 浙江工业大学 | 2022-03-25 | — | — | CN | disclosed |
| US-20220069354-A1 | SULFUR-BASED ELECTROLYTE SOLUTION FOR MAGNESIUM CELL | FUJIFILM WAKO PURE CHEMICAL CORPORATION (JP) | 2022-03-03 | — | — | US | disclosed |
| EP-3904337-A1 | SULFUR-BASED ELECTROLYTE SOLUTION FOR MAGNESIUM CELL | FUJIFILM Wako Pure Chemical Corporation (JP) | 2021-11-03 | — | — | EP | disclosed |
| CN-113166043-A | Electrolyte for sulfur-based magnesium battery | 富士胶片和光纯药株式会社 | 2021-07-23 | — | — | CN | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20220069354-A1 | SULFUR-BASED ELECTROLYTE SOLUTION FOR MAGNESIUM CELL | SLC26A3, PRDX4, PRDX2 | CES2 2991/4885CES1 2445/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.